Wedbush Starts NuPathe (PATH) at Outperform; Novel Drug Delivery for Better Patient Compliance
Go back to Wedbush Starts NuPathe (PATH) at Outperform; Novel Drug Delivery for Better Patient Compliance| NUPATHE (NYSE: PATH) | Delayed: 16.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.01 | 52 Week High | $4.49 | |||
| Open | $16.01 | 52 Week Low | $1.57 | |||
| Day High | $16.01 | P/E | N/A | |||
| Day Low | $16.01 | EPS | $-2.31 | |||
| Volume | 61,012 | |||||
